Assay development consulting services for ninds' heal program
Ended Purchase Order Awarded Last action
- Contract number
- 75N95021P00623
- Awardee
-
In Vitro Strategies LIMITED Liability Company UEI NFQKQ992KJD4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $32,403
Award facts
- Opportunity
-
- Assay Development Consulting Services Solicitation · NIHNINDSCSS21005325 · Posted Jul 21, 2021
- Contract value 7% obligated
-
- $32,402.50 Current, with exercised options
- $435,702.50 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 5 offers Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- Flemington, NJ 08822, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,430 | |
| Funding Only Action | -$1,468 | |
| Exercise an Option | $11,100 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $14,400 | |
| Other Administrative Action | $0 | |
| Original award | $10,800 |
About this award
The National Institute on Drug Abuse awarded a purchase order to In Vitro Strategies LIMITED Liability Company, a small business, valued at $435,702.50 on September 24, 2021, for assay development consulting services supporting the National Institutes of Health's Helping to End Addiction Long-term Initiative (HEAL Program).
Work is performed at the contractor's facility in Flemington, New Jersey. The order required a minimum of 20 hours of assay development consulting annually, with up to 780 optional additional hours per year, to advise lead development teams advancing projects from exploratory research through clinical trials. Key personnel must hold at least 15 years of assay development experience. The base period of performance was one year with options for two additional one-year periods. The ultimate completion date is September 29, 2024.
Through fiscal year 2023, the contractor invoiced $3,000 across 18 hours at a derived rate of $180.00 per hour, self-performing all reported work with no subcontractors.
Quick answers
Who was awarded contract 75N95021P00623?
75N95021P00623 was awarded to In Vitro Strategies LIMITED Liability Company by National Institute on Drug Abuse (National Institutes of Health) on September 24, 2021.
How much is contract 75N95021P00623 worth?
The government has obligated $32,403 on 75N95021P00623. Its potential value, with all options, is $435,703.
Was contract 75N95021P00623 competed?
The extent of competition for 75N95021P00623 was competed under sap. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award